| Year |
Citation |
Score |
| 2012 |
Waickman AT, Alme A, Senaldi L, Zarek PE, Horton M, Powell JD. Enhancement of tumor immunotherapy by deletion of the A 2A adenosine receptor Cancer Immunology, Immunotherapy. 61: 917-926. PMID 22116345 DOI: 10.1007/S00262-011-1155-7 |
0.546 |
|
| 2009 |
Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, Xiao B, Worley PF, Kozma SC, Powell JD. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity. 30: 832-44. PMID 19538929 DOI: 10.1016/J.Immuni.2009.04.014 |
0.598 |
|
| 2009 |
Scheibner KA, Boodoo S, Collins S, Black KE, Chan-Li Y, Zarek P, Powell JD, Horton MR. The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashion. American Journal of Respiratory Cell and Molecular Biology. 40: 251-9. PMID 18703794 DOI: 10.1165/Rcmb.2008-0168Oc |
0.49 |
|
| 2008 |
Collins S, Lutz MA, Zarek PE, Anders RA, Kersh GJ, Powell JD. Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. European Journal of Immunology. 38: 528-36. PMID 18203138 DOI: 10.1002/Eji.200737157 |
0.623 |
|
| 2008 |
Zarek PE, Huang CT, Lutz ER, Kowalski J, Horton MR, Linden J, Drake CG, Powell JD. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood. 111: 251-9. PMID 17909080 DOI: 10.1182/Blood-2007-03-081646 |
0.637 |
|
| 2007 |
Zarek PE, Powell JD. Adenosine and anergy. Autoimmunity. 40: 425-32. PMID 17729036 DOI: 10.1080/08916930701464939 |
0.663 |
|
| 2007 |
Zheng Y, Collins SL, Lutz MA, Allen AN, Kole TP, Zarek PE, Powell JD. A role for mammalian target of rapamycin in regulating T cell activation versus anergy. Journal of Immunology (Baltimore, Md. : 1950). 178: 2163-70. PMID 17277121 DOI: 10.4049/Jimmunol.178.4.2163 |
0.577 |
|
| Show low-probability matches. |